trifluoperazine has been researched along with Idiopathic Parkinson Disease in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (68.42) | 18.7374 |
| 1990's | 3 (15.79) | 18.2507 |
| 2000's | 1 (5.26) | 29.6817 |
| 2010's | 2 (10.53) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, Y | 1 |
| Nguyen, DT | 1 |
| Olzomer, EM | 1 |
| Poon, GP | 1 |
| Cole, NJ | 1 |
| Puvanendran, A | 1 |
| Phillips, BR | 1 |
| Hesselson, D | 1 |
| Höllerhage, M | 1 |
| Goebel, JN | 1 |
| de Andrade, A | 1 |
| Hildebrandt, T | 1 |
| Dolga, A | 1 |
| Culmsee, C | 1 |
| Oertel, WH | 1 |
| Hengerer, B | 1 |
| Höglinger, GU | 1 |
| BORENSTEIN, P | 1 |
| DABBAH, M | 1 |
| BLES, G | 1 |
| Sheppard, C | 1 |
| Merlis, S | 1 |
| Zweig, RM | 1 |
| Davis, PH | 1 |
| Shiwach, RS | 1 |
| Woods, S | 1 |
| Kristal, BS | 1 |
| Conway, AD | 1 |
| Brown, AM | 1 |
| Jain, JC | 1 |
| Ulluci, PA | 1 |
| Li, SW | 1 |
| Burke, WJ | 1 |
| Martin, IC | 1 |
| Hoehn, MM | 1 |
| Crowley, TJ | 1 |
| Rutledge, CO | 1 |
| Paulson, GW | 1 |
| Rizvi, CA | 1 |
| Crane, GE | 1 |
| Kurth, MC | 1 |
| Langston, JW | 1 |
| Tetrud, JW | 1 |
| Hershon, HI | 1 |
| Kennedy, PF | 1 |
| McGuire, RJ | 1 |
| Tkachev, RA | 1 |
| Markova, ED | 1 |
| Gotovtseva, EV | 1 |
| Barkhatova, VP | 1 |
| Ivanova-Smolenskaia, IA | 1 |
| Morrison, AB | 1 |
| Webster, RA | 1 |
| Ambani, LM | 1 |
| Van Woert, MH | 1 |
| Bowers, MB | 1 |
| Chase, TN | 1 |
| Schnur, JA | 1 |
| Gordon, EK | 1 |
| Jenkins, R | 1 |
| Hader, M | 1 |
| Ekdawi, MY | 1 |
| Fowke, R | 1 |
3 trials available for trifluoperazine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Implications of phenothiazine side effects: a study of antiparkinsonian agents in an older population.
Topics: Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Delayed-Action Preparat | 1975 |
Tardive dyskinesia as a possible sequel of long-term therapy with phenothiazines.
Topics: Adolescent; Child; Chlorpromazine; Clinical Trials as Topic; Diagnosis, Differential; Dystonia Muscu | 1975 |
Persistence of extra-pyramidal disorders and psychiatric relapse after withdrawal of long-term phenothiazine therapy.
Topics: Basal Ganglia Diseases; Clinical Trials as Topic; Factor Analysis, Statistical; Female; Humans; Male | 1972 |
16 other studies available for trifluoperazine and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
Rescue of Pink1 Deficiency by Stress-Dependent Activation of Autophagy.
Topics: Animals; Autophagy; Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; Behavior, Animal; C | 2017 |
Trifluoperazine rescues human dopaminergic cells from wild-type α-synuclein-induced toxicity.
Topics: alpha-Synuclein; Antipsychotic Agents; Autophagy; Cells, Cultured; Dopaminergic Neurons; Humans; Lew | 2014 |
[Apropos of the ultimate specificity of terrain in the appearance of extrapyramidal syndromes induced by neuroleptic agents].
Topics: Antipsychotic Agents; Basal Ganglia Diseases; Extrapyramidal Tracts; Haloperidol; Humans; Parkinson | 1962 |
Drug-induced extrapyramidal symptoms: their incidence and treatment.
Topics: Chlorpromazine; Chlorprothixene; Extrapyramidal Tracts; Female; Fluphenazine; Humans; Male; Parasymp | 1967 |
When selegiline is prescribed, Stelazine may be mistakenly dispensed.
Topics: Drug Prescriptions; Humans; Medication Errors; Parkinson Disease; Selegiline; Trifluoperazine | 1993 |
Risperidol and withdrawal bruxism in Lewy body dementia.
Topics: Aged; Antipsychotic Agents; Bruxism; Delusions; Dopamine Antagonists; Humans; Male; Parkinson Diseas | 1998 |
Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria.
Topics: 3,4-Dihydroxyphenylacetic Acid; 4-Aminobenzoic Acid; Aminobenzoates; Animals; Aristolochic Acids; Ce | 2001 |
The Parkinsonian syndrome and its dopamine correlates.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adult; Aged; Dopamine; Extrapyramidal Tracts; Female; Homovanillic A | 1977 |
"Stelazine" versus "selegiline"--a hazard in prescription writing.
Topics: Aged; Drug Prescriptions; Female; Humans; Male; Medication Errors; Parkinson Disease; Selegiline; Tr | 1990 |
[Principles of the pathogenetic therapy of congenital extrapyramidal diseases].
Topics: Adolescent; Adult; Atropine; Basal Ganglia Diseases; Chelating Agents; Chronic Disease; Dihydroxyphe | 1973 |
Drug-induced experimental Parkinsonism.
Topics: Animals; Atropine; Benztropine; Butyrophenones; Cats; Chlorpromazine; Dose-Response Relationship, Dr | 1973 |
Physostigmine effects on phenothiazine-induced extrapyramidal reactions.
Topics: Adult; Antiparkinson Agents; Chlorpromazine; Drug Hypersensitivity; Extrapyramidal Tracts; Female; H | 1973 |
Cerebrospinal fluid monoamine catabolites in drug-induced extrapyramidal disorders.
Topics: Amines; Brain; Chlorpromazine; Extrapyramidal Tracts; Female; Humans; Hydroxyindoleacetic Acid; Move | 1970 |
Laevo-dopa for Parkinsonism.
Topics: Dihydroxyphenylalanine; Haloperidol; Humans; Parkinson Disease; Trifluoperazine | 1970 |
Antiparkinsonism medication for the phenothiazine-induced pyramidal-extrapyramidal syndrome in elderly brain-damaged patients.
Topics: Aged; Brain Damage, Chronic; Chlorpromazine; Female; Humans; Male; Parkinson Disease; Perphenazine; | 1965 |
A controlled trial of anti-Parkinson drugs in drug-induced Parkinsonism.
Topics: Adolescent; Adult; Chlorpromazine; Haloperidol; Humans; Middle Aged; Orphenadrine; Parasympatholytic | 1966 |